Atlas Trials

Well-differentiated Non-functional NET of Gastrointestinal Origin

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Well-differentiated Non-functional NET of Gastrointestinal Origin

RecordFirmDate
Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) (NCT02955069)Novartis Pharmaceuticals2017-02-14

Track Well-differentiated Non-functional NET of Gastrointestinal Origin automatically

Every clearance here is in the API, with alerts when new ones post.